Literature DB >> 23934053

[Core set of behavioral recommendations for patients with ankylosing spondylitis].

E Feldtkeller1, G Lind-Albrecht, M Rudwaleit.   

Abstract

OBJECTIVES: Patients with ankylosing spondylitis (AS) can contribute to a favorable disease course by their own behaviour and environmental adaptations. However, no standardized consensus recommendations on patient behavior and adaptations exist, neither internationally nor nationally. The aim of this study was to establish a core set of recommendations concerning favorable patient behavior to be given to patients with AS by rheumatologists.
METHODS: An extended literature research in the scientific and patient-oriented literature revealed 70 recommendations. These recommendations were evaluated and ranked by importance at a meeting of the Ankylosing Spondylitis International Federation (ASIF, 26 participants from 13 countries) in November 2011. The remaining 59 recommendations were extensively discussed, supplemented, partially reworded, condensed and those with the highest priority were selected by consensus at a seminar of local branch leaders of the AS patient organization in Germany (Deutsche Vereinigung Morbus Bechterew) in March 2012 (80 participants, 95% patients with AS).
RESULTS: The core set encompasses 1) a general statement on living with AS and 2) recommendations in the areas of sitting position, walking, sleeping, at work, exercising, sports and recreational activities, diet and life style, sexuality and pregnancy, fall prevention, car driving and membership in an AS-specific patient organization. The selected recommendations received agreement by 80-100% of the patients. Some recommendations (e.g. fall prevention and car driving) are more relevant to patients with advanced and usually longstanding disease, i.e. with advanced ankylosis or osteoporosis.
CONCLUSIONS: For the first time a core set of recommendations for the behavior of patients with AS was created in collaboration with many persons affected by the disease. Patients with AS should receive these recommendations from their rheumatologists, ideally early in the disease course. The German version of this core set is presented in this article.

Entities:  

Mesh:

Year:  2013        PMID: 23934053     DOI: 10.1007/s00393-013-1233-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  17 in total

1.  Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis.

Authors:  Michael M Ward; Matthew R Hendrey; James D Malley; Thomas J Learch; John C Davis; John D Reveille; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2009-07-15

2.  Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort.

Authors:  Ho Yin Chung; Pedro Machado; Désirée van der Heijde; Maria-Antonietta D'Agostino; Maxime Dougados
Journal:  Ann Rheum Dis       Date:  2011-10-11       Impact factor: 19.103

3.  Home-based exercise therapy in patients with ankylosing spondylitis: effects on pain, mobility, disease activity, quality of life, and respiratory functions.

Authors:  Ebru Aytekin; Nil Sayıner Caglar; Levent Ozgonenel; Sule Tutun; Dilay Yilmaz Demiryontar; Saliha Eroglu Demir
Journal:  Clin Rheumatol       Date:  2011-06-10       Impact factor: 2.980

4.  [Advice for patients diagnosed with ankylosing spondylitis: results of a representative patient survey in Germany].

Authors:  E Feldtkeller; L Hammel; C Brenneis; I-H Song; M Rudwaleit
Journal:  Z Rheumatol       Date:  2011-07       Impact factor: 1.372

5.  Relationship between smoking and patient-reported measures of disease outcome in ankylosing spondylitis.

Authors:  Derek L Mattey; Sarah R Dawson; Emma L Healey; Jonathan C Packham
Journal:  J Rheumatol       Date:  2011-10-01       Impact factor: 4.666

6.  Smoking and outcome in ankylosing spondylitis.

Authors:  H L Averns; J Oxtoby; H G Taylor; P W Jones; K Dziedzic; P T Dawes
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

7.  [German patient version of the ASAS/EULAR recommendations for the management of ankylosing spondylitis].

Authors:  U Kiltz; E Feldtkeller; J Braun
Journal:  Z Rheumatol       Date:  2010-03       Impact factor: 1.372

8.  Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis.

Authors:  Olaf Adam; Corinna Beringer; Thomas Kless; Christa Lemmen; Alexander Adam; Michael Wiseman; Patrick Adam; Reinhard Klimmek; Wolfgang Forth
Journal:  Rheumatol Int       Date:  2002-09-06       Impact factor: 2.631

9.  Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis.

Authors:  Uzunca Kaan; Ozdemir Ferda
Journal:  Rheumatol Int       Date:  2004-02-27       Impact factor: 2.631

10.  2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Braun; R van den Berg; X Baraliakos; H Boehm; R Burgos-Vargas; E Collantes-Estevez; H Dagfinrud; B Dijkmans; M Dougados; P Emery; P Geher; M Hammoudeh; R D Inman; M Jongkees; M A Khan; U Kiltz; Tk Kvien; M Leirisalo-Repo; W P Maksymowych; I Olivieri; K Pavelka; J Sieper; E Stanislawska-Biernat; D Wendling; S Ozgocmen; C van Drogen; Bj van Royen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103

View more
  1 in total

1.  [Patient information and shared decision-making in orthopaedics].

Authors:  Ernst Feldtkeller
Journal:  Orthopade       Date:  2019-11       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.